These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 113205)

  • 1. Experimental anticonvulsant cinromide in monkey model: preliminary efficacy.
    Lockard JS; Levy RH; DuCharme LL; Congdon WC
    Epilepsia; 1979 Aug; 20(4):339-50. PubMed ID: 113205
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cinromide's metabolite in monkey model: gastric administration and seizure control.
    Lockard JS; Levy RH; DuCharme LL; Congdon WC
    Epilepsia; 1980 Apr; 21(2):177-82. PubMed ID: 6766857
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clonazepam in a focal-motor monkey model: efficacy, tolerance, toxicity, withdrawal, and management.
    Lockard JS; Levy RH; Congdon WC; DuCharme LL; Salonen LD
    Epilepsia; 1979 Dec; 20(6):683-95. PubMed ID: 115680
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fractions metabolized in a triangular metabolic system: cinromide and two metabolites in the rhesus monkey.
    Lane EA; Levy RH
    J Pharmacokinet Biopharm; 1985 Aug; 13(4):373-86. PubMed ID: 4087169
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of cinromide on "kindled" seizures in the rat.
    Chiu P; Lipnowski S; Bruni J; Burnham WM
    Neuropharmacology; 1982 Mar; 21(3):273-6. PubMed ID: 7070603
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential kinetics of cinromide and two of its metabolites in epileptic patients.
    Wilensky AJ; Lane EA; Levy RH; Ojemann LM; Friel PN
    Eur J Clin Pharmacol; 1981; 21(2):149-53. PubMed ID: 7341282
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Influence of cinromide on metrazol--induced seizures during ontogenesis in rats.
    Bernásková K; Mares P; Rokyta R
    Physiol Bohemoslov; 1988; 37(2):123-30. PubMed ID: 2975002
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prophylaxis with diphenylhydantoin and phenobarbital and alumina-gel monkey model. I. Twelve months of treatment: seizure, EEG, blood, and behavioral data.
    Lockard JS; Congdon WC; DuCharme LL; Huntsman BJ
    Epilepsia; 1976 Mar; 17(1):37-47. PubMed ID: 817891
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of cinromide on inhibitory and excitatory mechanisms.
    Fromm GH; Terrence CF; Chattha AS
    Epilepsia; 1983 Aug; 24(4):394-400. PubMed ID: 6307676
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetic relationships between cinromide and its metabolites in the rhesus monkey I: 3-Bromocinnamamide, an active metabolite.
    Lane EA; Levy RH
    J Pharm Sci; 1983 May; 72(5):493-6. PubMed ID: 6864493
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Simultaneous determination of the anticonvulsants, cinromide (3-bromo-n-ethylcinnamamide), 3-bromocinnamamide, and carbamazepine in plasma by high-performance liquid chromatography.
    Perchalski RJ; Bruni J; Wilder BJ; Willmore LJ
    J Chromatogr; 1979 Jun; 163(2):187-93. PubMed ID: 541370
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vivo evaluation of the Michaelis-Menten constant for a medium extraction ratio drug: application to cinromide in the rhesus monkey.
    Lane EA; Levy RH
    J Pharm Sci; 1983 Nov; 72(11):1352-4. PubMed ID: 6644604
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy and toxicity of the solvent polyethylene glycol 400 in monkey model.
    Lockard JS; Levy RH; Congdon WC; DuCharme LL
    Epilepsia; 1979 Feb; 20(1):77-84. PubMed ID: 105903
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Carbamazepine revisited in a monkey model.
    Lockard JS; Levy RH; DuCharme LL; Congdon WC; Patel IH
    Epilepsia; 1979 Apr; 20(2):169-73. PubMed ID: 110585
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy of standard anticonvulsants in monkey model with spontaneous motor seizures.
    Lockard JS; Uhlir V; DuCharme LL; Farquhar JA; Huntsman BJ
    Epilepsia; 1975 Jun; 16(2):301-17. PubMed ID: 1171007
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cinromide in epilepsy: a pilot study.
    Wilensky AJ; Ojemann LM; Friel PN; Almes MJ; Levy RH; Dodrill CB
    Epilepsia; 1983 Aug; 24(4):401-9. PubMed ID: 6409598
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A double-blind crossover study of cinromide versus placebo in epileptic outpatients with partial seizures.
    Spilker B; Bruni J; Jones M; Upton A; Cato A; Cloutier G
    Epilepsia; 1983 Aug; 24(4):410-21. PubMed ID: 6409599
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prophylaxis with diphenylhydantoin and phenobarbital in alumina-gel monkey model. II. Fourth-month follow-up period: seizure, EEG, blood and behavioral data.
    Lockard JS; DuCharme LL; Congdon WC; Franklin SC
    Epilepsia; 1976 Mar; 17(1):49-57. PubMed ID: 817892
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quantitation of the anticonvulsant cinromide (3-bromo-N-ethylcinnamamide) and its major plasma metabolites by thin-layer chromatography.
    DeAngelis RL; Robinson MM; Brown AR; Johnson TE; Welch RM
    J Chromatogr; 1980 Dec; 221(2):353-60. PubMed ID: 7217303
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genetic animal models of epilepsy as a unique resource for the evaluation of anticonvulsant drugs. A review.
    Löscher W
    Methods Find Exp Clin Pharmacol; 1984 Sep; 6(9):531-47. PubMed ID: 6439966
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.